Corticosteroid-sparing therapy: practice patterns among uveitis specialists
نویسندگان
چکیده
منابع مشابه
Corticosteroid-sparing therapy: practice patterns among uveitis specialists
PURPOSE This study aims to determine uveitis specialists' practice patterns, preferences, and perceptions of corticosteroid-sparing therapies for the initial treatment of chronic noninfectious uveitis. METHODS A survey was distributed to the American Uveitis Society and Proctor email listservs in order to restrict the respondents to specialists who likely have extensive experience in the use ...
متن کاملTopical management of psoriasis - corticosteroids and sparing corticosteroid therapy.
Psoriasis is a complex disease that requires safe, long-term treatment. Topical steroid therapy, topical non-steroid therapy only, and a combination of various topical therapies in the treatment of mild to moderate forms of psoriasis are presented. Topical therapy includes corticosteroids, vitamin D3 analogs, retinoids, tars, anthralin, keratolytics, and topical immunomodulators. While most med...
متن کاملSurveying uveitis specialists—a call for consensus
In the early 1990s, former Michigan supreme court Justice Thomas Brennan became disillusioned with popular law school rankings and so decided to survey 100 academics, judges, and lawyers on his own, asking them to rank a list of ten schools he provided. He used a composite index similar in structure, but different in content, to those used by mainstream surveyors, such as U.S. News & World Repo...
متن کاملComment on : Tocilizumab induces corticosteroid sparing in rheumatoid arthritis patients in clinical practice
SIR, I was pleased to read the recent article on the short-term value of tocilizumab (TCZ) in decreasing the daily oral prednisone dose (DOPD) in RA patients in a real-life setting [1]. The proportion of RA patients receiving TCZ with a DOPD of 45 mg increased from 32% at baseline to 54% after 24 weeks and 12% were off prednisone at 24 weeks [1]. However, I have some concerns about the study de...
متن کاملComment on: tocilizumab induces corticosteroid sparing in rheumatoid arthritis patients in clinical practice: reply.
SIR, I was pleased to read the recent article on the short-term value of tocilizumab (TCZ) in decreasing the daily oral prednisone dose (DOPD) in RA patients in a real-life setting [1]. The proportion of RA patients receiving TCZ with a DOPD of 45 mg increased from 32% at baseline to 54% after 24 weeks and 12% were off prednisone at 24 weeks [1]. However, I have some concerns about the study de...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Ophthalmic Inflammation and Infection
سال: 2011
ISSN: 1869-5760
DOI: 10.1007/s12348-011-0047-5